+1-888-308-5802     
Industry Categories News Contact Us

Travelport, IBM partnership to develop innovations for travel industry

Author : Pankaj Singh | Published Date : 2018-10-25 

Leading travel commerce platform Travelport has recently made an announcement saying it is expanding its existing partnership with IBM for developing innovations that would disrupt the travel industry. The company said it had completed a proof of concept for streamlining the validation, distribution and settlement of hotel content, using IBM Blockchain, between travel agencies and hotels and its own platform.

According to the announcement, the first of the two programs involves going forward to the next phase of development to streamline the hotel as well as in-trip experience ecosystem using IBM Blockchain. Offer choices through content, seamless booking and fulfilment experience are considered imperative for traveler satisfaction.

Travelport and IBM jointly determined that blockchain could help in providing travel agencies confidence in ease of sale and travel experience by managing content. Long-tail content suppliers would also be able to participate efficiently.

Working with IBM would remove barriers that limit choices in travel, said Travelport’s Chief Architect, Mike Croucher. The operator will hold the ability to upload bookings, work through contacts and administrative functions within the blockchain network, instead of the expensive way of manually managing and owning such tasks, he stated.

Elizabeth Pollock, Industry Client Leader at IBM Travel & Transportation, mentioned that by implementing a smart contract across a distributed ledger, settling payments within the blockchain network and so on, the blockchain technology considerably reduces the processing time. Transparency in the system across all parties is another benefit of the technology, she added.

As part of the second initiative, Travelport and IBM will work towards generating enhanced travel experiences by taking advantage of the vast travel data held by Travelport. By applying the Watson Analytics Studio of IBM, Travelport would look to develop new services, like personalized recommendations or highlighting the best time to buy, based on previously compiled travel data. 

These tools will allow travel agency subscribers to offer more value to the travelers they serve, the company claims. Supposedly, Travelport’s wide range of travel supplier content will also become easily accessible for the travelers.

About Author

Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With experience in technical and niche writing, he was encouraged to opt for a career in content writing and now pens down articles pertaining to market research, industry news and business trends.

He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Communications firm Telstra all set to introduce 5G devices in H1 2019

Published Date: 2019-01-11         Author: Pankaj Singh

It’s likely that Telstra may be the only Australian telco to sell 5G phones in the first half of the year. Telstra Corp Lt. Australia’s largest telecom firm, has apparently rung in the New Year with plans to soon roll-out smartphones compatible with 5G. The company’s chief execu... Read More

UK supermarkets issue recall for items reported to pose health risks

Published Date: 2018-11-19         Author: Pankaj Singh

Reports confirm that major supermarkets including Asda, Lidl, Sainsbury’s, Tesco and Waitrose have discovered problems with some food items they sell which could mean a health risk for consumers. Customers are being asked to return these items to the stores for a full refund, said sources fami... Read More

Cipla agrees to buy U.S.-based Avenue Therapeutics in a $215m deal

Published Date: 2018-11-14         Author: Pankaj Singh

Pharmaceutical drug giant Cipla recently confirmed that its U.S.-based subsidiary, InvaGen Pharmaceuticals, Inc. has signed definitive agreements for acquiring specialty pharmaceutical company Avenue Therapeutics, also from the U.S. The deal is reported to be valued at US$ 215 million (approx. Rs 1,... Read More

© 2019 Fractovia. All Rights Reserved